Home  About us  Contact
 

Jewish Women (jewish + woman)

Distribution by Scientific Domains
Humanities and Social Sciences42%

Selected Abstracts

Jewish Women in Fin de Siècle Vienna by Alison Rose

GENDER & HISTORY, Issue 2 2010
JONATHAN KWAN
No abstract is available for this article. [source]

The Stains of Culture: An Ethno-Reading of Karaite Jewish Women by Ruth Tsoffar

AMERICAN ETHNOLOGIST, Issue 1 2010
SHARI JACOBSON
No abstract is available for this article. [source]

Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency

HAEMOPHILIA, Issue 2 2002
P. LAWLER
Factor XI (FXI) inhibitors are a rare complication of inherited FXI deficiency. We report the successful use of recombinant factor VIIa (FVIIa) in a patient with a high-responding inhibitor undergoing cataract extraction. At the time of surgery there were limited available data on the optimal management of patients with FXI deficiency. A 62-year-old Ashkenazi Jewish woman had a lifelong history of excessive bleeding secondary to severe FXI deficiency (2 U dL,1), and received FXI concentrate (FXI:C) when she underwent a colposuspension procedure. She was subsequently diagnosed with a FXI inhibitor of 16 Bethesda units (BU) when she developed a poor response to FXI:C at the time of total hip replacement. Two months later she was admitted for cataract extraction. The FXI level was < 1 U dL,1 with an inhibitor titre of 48 BU. She received 90 ,g kg,1 of FVIIa immediately preoperatively followed by continuous infusion at a rate of 20 ,g kg,1 h,1 for 24 h. The cataract extraction was successful and there was no excess bleeding during surgery or in the postoperative period. Mutation analysis of the FXI gene showed that the patient was homozygous for the type II genotype [exon 5, Glu117,Ter]. The reason for the low prevalence of inhibitor formation in patients with FXI deficiency is unclear but may reflect a number of factors including reporting bias, the rarity of absent circulating FXI:C activity, and the infrequent use of FXI replacement therapy. [source]

Screening for factor XI deficiency amongst pregnant women of Ashkenazi Jewish origin

HAEMOPHILIA, Issue 6 2006
R. A. KADIR
Summary., A pilot study was conducted over a 6-month period to evaluate antenatal screening for factor XI (FXI) deficiency amongst Ashkenazi Jewish women booking for their pregnancy in a single obstetric unit. Fifty-four women of Ashkenazi Jewish origin were recruited during their visit for the routine first trimester ultrasound scan. They completed a questionnaire about their personal bleeding symptoms and had blood taken for FXI levels (FXI:C). Seven (13%) women had partial FXI deficiency. Five (9%) were newly diagnosed, and in the remaining two, the diagnosis was known previously. One infant with severe FXI deficiency was identified as a result of maternal testing. This study has shown that FXI deficiency is common amongst women of Ashkenazi Jewish origin and supports its antenatal screening in this population. However, further studies are required to evaluate its cost-effectiveness and the effect on pregnancy outcome. [source]

Exploring internalized oppression and healing strategies

NEW DIRECTIONS FOR ADULT & CONTINUING EDUCATION, Issue 94 2002
Penny Rosenwasser
Jewish women use collaborative inquiry to heal from internalized anti-Semitism. They build community by using action-reflection cycles, wholistic ways of knowing, emotional probing, and validity procedures. [source]

A Merger of Movements: Peace and Civil Rights Activism in Postwar Miami

PEACE & CHANGE, Issue 2 2010
Raymond A. Mohl
This article suggests the importance of studying local peace movements in postwar America, as civil rights historians have been doing for two decades. The article also argues that peace and civil rights often reflected the same progressive impulse for social justice,thus the importance of exploring the relationships and interconnections between the two movements. This case study of peace and civil rights in postwar Miami documents the role of politically progressive Jews, especially Jewish women, in forging a social justice movement focused on peace, civil liberties, and civil rights. Mostly newcomers from northern cities, a small group of activist Jews played a major organizational role in local branches of such civil rights and peace groups as the Civil Rights Congress, the Congress of Racial Equality, the Women's International League for Peace and Freedom, the National Committee for a Sane Nuclear Policy, and Women Strike for Peace. For those who chose the activist path, peace and civil rights became inseparable components of a local social justice crusade challenging racial segregation and national Cold War policies. [source]

Impact of BRCA mutations on female fertility and offspring sex ratio,

AMERICAN JOURNAL OF HUMAN BIOLOGY, Issue 2 2010
Roxana Moslehi
Positive selection for inherited mutations in breast and ovarian cancer predisposing genes, BRCA1 and BRCA2, may contribute to the high frequency of BRCA mutations among the Ashkenazi Jewish population. Impact of BRCA mutations on fertility has not been generally explored in epidemiologic studies. There are reports of distorted sex ratios in BRCA carrier families but these findings have been attributed to bias. We investigated the effect of BRCA mutations on female fertility and offspring sex ratio in a study of 260 Ashkenazi Jewish women with ovarian cancer and 331 controls, unselected for age or family history of the disease. Pregnancy success was similar for 96 mutation carrier (0.84) and 164 noncarrier cases (0.87) and controls (0.83). After adjusting for covariates, there were no significant differences between BRCA carrier and noncarrier cases and controls with regards to fertility, despite lower pregnancy rates among all cases compared to controls (P = 0.0049). Male/female sex ratios were significantly lower among offspring of carriers (0.71) than offspring of noncarriers (0.95) or those of the controls (0.99). Comparisons among the three groups yielded statistically significant distortion against males among the offspring of known and obligate BRCA carriers compared to noncarriers (OR = 0.74, 95% CI:0.55,0.99) and controls (OR = 0.71, 95% CI:0.54,0.94). In conclusion, we did not find evidence for an effect of BRCA mutations on female fertility. We found a significant excess of females among the offspring of female carriers of BRCA1 and BRCA2 mutations. Potential contribution of observed sex ratio distortions to positive selection for BRCA mutations may warrant further investigation. Am. J. Hum. Biol., 2010. © 2009 Wiley-Liss, Inc. [source]